Evidence map›Paper›PMID 32519146›Full record

ArticleAnnals of surgical oncology2020

Perineural Invasion is a Better Prognostic Indicator than Lymphovascular Invasion and a Potential Adjuvant Therapy Indicator for pN0M0 Esophageal Squamous Cell Carcinoma.

Yuan-Ning Guo, Dong-Ping Tian, Qing-Yun Gong, Hao Huang, Peng Yang, Shao-Bin Chen, Salem Billan, Jia-Yu He, Hai-Hua Huang, Pan Xiong and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Increased Nerve Density Adversely Affects Outcome in Oral Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yuan-Ning Guo *Department of Pathology and Institute of Clinical Pathology, Shantou University Medical College, Shantou, China.ORCID http://orcid.org/0000-0002-1391-0914
Dong-Ping Tian *Department of Pathology and Institute of Clinical Pathology, Shantou University Medical College, Shantou, China.ORCID http://orcid.org/0000-0002-9152-0532
Qing-Yun GongDepartment of Pathology and Institute of Clinical Pathology, Shantou University Medical College, Shantou, China.ORCID http://orcid.org/0000-0003-1306-6140
Hao HuangDepartment of Pathology and Institute of Clinical Pathology, Shantou University Medical College, Shantou, China.ORCID http://orcid.org/0000-0002-3320-8348
Peng YangDepartment of Pathology and Institute of Clinical Pathology, Shantou University Medical College, Shantou, China.ORCID http://orcid.org/0000-0002-5996-2429
Shao-Bin ChenDepartment of Thoracic Surgery, Cancer Hospital of Shantou University Medical College, Shantou, China.
Salem BillanThe Radiation Oncology Institute, The Head and Neck Center, Rambam Healthcare Campus, Haifa, Israel.
Jia-Yu HeDepartment of Pathology and Institute of Clinical Pathology, Shantou University Medical College, Shantou, China.ORCID http://orcid.org/0000-0002-3624-1178
Hai-Hua HuangDepartment of Pathology, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China.
Pan XiongDepartment of Pathology and Institute of Clinical Pathology, Shantou University Medical College, Shantou, China.ORCID http://orcid.org/0000-0001-6381-6291
Wen-Ting LinDepartment of Pathology and Institute of Clinical Pathology, Shantou University Medical College, Shantou, China.
Dan GuoDepartment of Pathology and Institute of Clinical Pathology, Shantou University Medical College, Shantou, China.
Moshe MaromGuangdong Dynavolt Renewable Energy Technology, Shantou, China.
Ziv GilThe Laboratory for Applied Cancer Research, The Head and Neck Center, Department of Otolaryngology Head and Neck Surgery, Technion - Israel Institute of Technology, Haifa, Israel. ziv@baseofskull.org.ORCID http://orcid.org/0000-0001-5390-9507
Min SuDepartment of Pathology and Institute of Clinical Pathology, Shantou University Medical College, Shantou, China. minsu@stu.edu.cn.ORCID http://orcid.org/0000-0003-3589-9573

Funding

Li Ka Shing Foundation Grant for Joint Research Program between Shantou University and Technion-Israel Institute of Technology 43209505National Natural Science Foundation of China 81572684National Natural Science Foundation of China 81772997
6 · The paper itself

Abstract

backgroundEsophageal squamous cell carcinoma (ESCC) at pN0M0 can be more locally aggressive and disseminated than those with lymph node and distant metastasis. Perineural invasion (PNI) is reported as a poor prognostic factor in cancer and is thought to be related to regional tumor spread and metastasis. However, its clinicopathological role and meaning for treatment in pN0M0 ESCC are unknown. PATIENTS AND

methodsWe applied scoring methods of PNI and lymphatic and vascular invasion (LI, VI) based on immunohistochemistry staining on tumor tissues of pN0M0 ESCC patients. ROC analyses, Kaplan-Meier analyses, Cox regression, and χ

resultsPresence of PNI was significantly associated with poor survival in pN0M0 patients, whereas LI and VI were not predictive of outcome (P > 0.05). Neural invasion index (NII), defined as the ratio of the number of tumor-invaded nerves to the total number of nerves per tumor microsection, was the most consistent measure of PNI (P = 0.006, HR = 6.892, 1.731-27.428). Postoperative radiotherapy significantly improved survival in high-NII patients (P = 0.035, HR = 0.390, 0.163-0.936).

conclusionsPNI is an important risk factor for the outcome of pN0M0 ESCC patients. NII can be used for risk assessment and to tailor adjuvant radiotherapy in this population.

Indexed as

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaPeripheral NervesHumansLymphatic MetastasisNeoplasm InvasivenessNeoplasm StagingPrognosisRetrospective Studies

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.